T1	Participants 289 361	in patients with chronic immune thrombocytopenia during a 6-month period
T2	Participants 434 581	in adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L
T3	Participants 1508 1520	197 patients
T4	Participants 2860 2928	patients who have not responded to splenectomy or previous treatment
